About Neuland Labs
Neuland Labs is a publicly listed company based in Hyderabad (India) founded in 1984 by Davuluri Sucheth Rao. It operates as an active pharmaceutical ingredients and peptides are manufactured globally. It operates on a Professional Services and HealthTech model. The company has 1,790 employees. Neuland Labs has completed 1 acquisition, including Arch Pharmalabs. Its chief executive is Davuluri Sucheth Rao. Its website neulandlabs.com draws about 21 thousand monthly visits. Its Indian entity Neuland Laboratories Ltd. reported revenue of ₹1,497 Cr. Neuland Labs offers products and services including Generic APIs, CDMO Services, and Peptide Development. Its focus areas include Pharmaceuticals and Active Pharmaceutical Ingredients. Its competitors include Laurus Labs, Symbiotec, Provepharm Life Solutions, SeQuent and Sterling Pharma Solutions and 4 more; 3 of its 9 listed competitors have raised funding.
Company details
Neuland Labs is involved in the development and manufacturing of active pharmaceutical ingredients (APIs) and offers contract development and manufacturing organization (CDMO) services. The company serves over 500 pharmaceutical and biotech organizations across 80 countries. Operations are focused on generic APIs, custom drug development, and peptide synthesis. Solutions are provided for early-stage drug development through commercial manufacturing, emphasizing quality, compliance, and innovation. Sectors served include healthcare and pharmaceuticals, with a commitment to sustainability and environmental responsibility integrated into processes.
- Headquarters Hyderabad, India
- Employees 1,790
- Founders Davuluri Sucheth Rao
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Phone•••• ••••
- Website neulandlabs.com/en
- Social LinkedIn X Facebook YouTube
- Legal Name Neuland Laboratories Ltd.
- Annual Revenue₹1,497 Cr
FY 2025 · -5% YoY
- Net Profit₹260 Cr
FY 2025 · 17% margin
- EBITDA₹420 Cr
FY 2025 · 28% margin
- Latest Funding Round$18.35M (USD), Post-IPO
May 2018
- Investors
- Employee Count1,790
- Investments & Acquisitions
Associated legal entities of Neuland Labs
Neuland Labs operates through Neuland Laboratories Ltd., a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Neuland Laboratories Ltd. Listed CIN L85195TG1984PLC004393 | Active | 07 Jan 1984 | Hyderabad, Telangana | ₹1,497 Cr | 1,860 | 11 | View details |
Products & Services of Neuland Labs
Neuland Labs offers a comprehensive portfolio of products and services, including Generic APIs, CDMO Services, and Peptide Development.
Generic APIs are manufactured for various therapeutic categories.
Custom drug development services are provided end-to-end comprehensively.
Peptide synthesis services are offered at various scales.
Apps and channels of Neuland Labs
its YouTube channel Neuland Laboratories has 413 subscribers and 9 videos.
Videos from Neuland Labs
The most watched videos on Neuland Labs's YouTube channel, Neuland Laboratories (413 subscribers). Click a video to play it here.
More on Neuland Laboratories.
Funding Insights of Neuland Labs
- Total Rounds 2
- Last Round Post-IPO — $18.35M
- First Round $8.4M
(Dec 2012)
- Investors Count 1
All 2 funding rounds of Neuland Labs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2018 | $18.35M | Post-IPO | – | – | – |
| Dec 2012 | $8.4M | Post-IPO | – | – |
1 investors in total: 1 institutional.
Investors in Neuland Labs
Neuland Labs has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Evolvence.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Holding company focused on asset management, education and retail | 2001 | evolvence.com | Dubai, United Arab Emirates |
Investor details for Neuland Labs
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Neuland Laboratories Ltd. (Neuland Labs)
Neuland Laboratories Ltd. is the primary company behind Neuland Labs. The board of Neuland Laboratories Ltd. currently have 9 directors; the longest-serving is Ramamohan Rao Davuluri, appointed in 1984. 24 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ramamohan Rao Davuluri DIN 00107737 | Whole-time director | 07 Jan 1984 | 42 yrs 9 mo | Neuland Laboratories Ltd. |
| Sucheth Rao Davuluri DIN 00108880 | Whole-time director | 29 Jul 2003 | 23 yrs 2 mo | Neuland Laboratories Ltd. |
| Saharsh Rao Davuluri DIN 02753145 | Whole-time director | 01 Jun 2009 | 17 yrs 4 mo | Neuland Laboratories Ltd. |
| Homi Rustam Khusrokhan DIN 00005085 | Director | 12 Feb 2019 | 7 yrs 8 mo | Neuland Laboratories Ltd. |
| Prasad Raghava Menon DIN 00005078 | Director | 31 Oct 2022 | 3 yrs 11 mo | Neuland Laboratories Ltd. |
| Sugata Sircar DIN 01119161 | Director | 27 Jun 2023 | 3 yrs 3 mo | Neuland Laboratories Ltd. |
| Pallavi Joshi Bakhru DIN 01526618 | Director | 27 Jun 2023 | 3 yrs 3 mo | Neuland Laboratories Ltd. |
| Ravi Shankar Gopinath DIN 00803847 | Director | 01 Aug 2025 | 1 yr 2 mo | Neuland Laboratories Ltd. |
| Mauricio Futran DIN 11699767 | Additional Director | 12 May 2026 | 5 mo | Neuland Laboratories Ltd. |
People of Neuland Labs
53 people are tracked at Neuland Labs (23 in leadership, 8 in board & advisors, 22 in team); the tracked headcount is 1,790.
| Name | Role | Group |
|---|---|---|
| Founder & CEO | Leadership | |
K V Sharadsrikar | Chief Scientific Officer | Leadership |
Amol Pitale | GM HR L&od And Business Partner R&d | Leadership |
Raghunath Talakayala | Assistant General Manager | Leadership |
Arnab Roy | Director (gm) | Leadership |
Hemchandra Peruvelli | Chief Human Resources Officer | Leadership |
Bharadwaj Gollapudi | Associate Vice President - Finance And Accounts | Leadership |
Rachna Chhabra | General Manager - Head Ta, OD & HRBP (corporate) | Leadership |
Nomula Venkat | Presales Head AGM | Leadership |
Shashank Mahashabde | President, Business Development And Contract Manufacturing | Leadership |
Sundar Narsimhan | Chief Procurement Officer | Leadership |
Dorothy Paul | Chief Marketing & Communications Officer | Leadership |
Abhijit Majumdar | Chief Financial Officer | Leadership |
Murali Krishna | Head Of Quality Control | Leadership |
Vivek Thakare | Assistant General Manager | Leadership |
Sudheer Ranga | Deputy General Manager | Leadership |
V K Prasad Jonnalagadda | Associate Director | Leadership |
Ashutosh Kumar Sinha | Chief Quality Officer | Leadership |
Sharadsrikar Kotturi | Chief Scientific Officer | Leadership |
Ravi Chittuluri | General Manager Human Resources | Leadership |
33 more people are available in the full profile.
Complete people profiles for Neuland Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Neuland Labs
Neuland Labs is a publicly listed company on the NSE with ticker symbol NEULANDLAB in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date13 Oct 2008
- Listed onNSE: NEULANDLAB
- Listed entityNeuland Laboratories Ltd.
- Exchange sectorHealth technology
- ISININE794A01010
- Share price₹20,225.00 (-0.66% on the day) · 2026-10-14
- Market capitalisation₹26,111 Cr
- Price to earnings52.1
- EPS (diluted, trailing year)₹387.98
- Dividend yield0.17%
- Volume (last session)15,399
Financials of Neuland Labs
Figures of Neuland Laboratories Ltd., the primary company behind Neuland Labs, for FY 2025. Revenue was ₹1,497 Cr (-5% year on year). Net profit was ₹260 Cr (17% margin). EBITDA was ₹420 Cr (28% margin). Revenue has grown at a compounded annual rate of +16% over three years and +14% over five years.
- ₹1,497 CrRevenue · FY 2025 · -5% YoY
- ₹260 CrNet profit · 17% margin
- ₹420 CrEBITDA · 28% margin
- ₹12.83 CrPaid-up capital
- 1,860Employees (provident fund records)
- +16%Revenue CAGR, 3 years
- +14%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | ₹1,999 Cr | ₹364 Cr | ₹561 Cr |
| 2024 | ₹1,454 Cr | ₹260 Cr | ₹312 Cr |
| 2023 | ₹1,535 Cr | ₹300 Cr | ₹446 Cr |
| 2022 | ₹1,176 Cr | ₹164 Cr | ₹269 Cr |
| 2021 | ₹934 Cr | ₹63.8 Cr | ₹129 Cr |
Balance sheet, profit and loss, cash flow and ratios of Neuland Laboratories Ltd. are on its company page.
Detailed financial statements for Neuland Labs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Neuland Labs
Neuland Labs has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Arch Pharmalabs.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
API manufacturer & supplier, also offering custom synthesis and contract manufacturing services | archpharmalabs.com | Mumbai, India | 1999 | Dec 2017 | •••• |
Complete acquisition details for Neuland Labs
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Neuland Labs
5 dated milestones of Neuland Labs across 34 years, from founding to its latest funding, stage changes and deals.
- Founded Neuland Labs is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $8.4M.
- Acquisition Acquires Arch Pharmalabs.
- Funding Latest funding round, Post-IPO, of $18.4M.
Competitors of Neuland Labs
Neuland Labs has 9 listed competitors in our database, 3 of them funded. They include Laurus Labs, Symbiotec, Provepharm Life Solutions, SeQuent and Sterling Pharma Solutions, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| provepharm.com | 1998 | Marseille, France | $145.93M | – | APIs and drug products are developed and valorized in pharmaceuticals. | |
| sequent.in | 2002 | Bengaluru, India | – | – | APIs are developed and manufactured for therapeutic areas. | |
| sterlingpharmasolutions.com | 2016 | Dudley, United Kingdom | – | 560 | Contract development, manufacturing, and analytical services for APIs are offered. | |
| snapdragonchemistry.com | 2014 | Cambridge, United States | – | 43 | Drug discovery and development service provider | |
| jubilantpharma.com | 1978 | Noida, India | – | – | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | |
| hikal.com | 1988 | Mumbai, India | – | 355 | APIs and intermediates are produced via custom synthesis and research. | |
| stpharm.co.kr | 2008 | – | – | – | Oligonucleotide, mRNA, and small molecule CDMO services are provided. |
Detailed competitors of Neuland Labs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Neuland Labs
The website of Neuland Labs (neulandlabs.com) receives about 20.8K visits a month and ranks #904,182 among all websites worldwide, #1,083 in Biotechnology and Pharmaceuticals.
- Monthly visits20.8K
▼ 9.2% vs previous month
- Unique visitors9.8K
per month
- Global rank#904,182
among all websites
- Category rank#1,083
Health · Biotechnology and Pharmaceuticals
- Bounce rate35%
- Pages per visit4.4
- Average visit1 min 58 sec
- DevicesDesktop 18% · Mobile 82%
Websites whose visitors overlap most with Neuland Labs. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| enzal.com | 100% | – | – | View details | |
| u-g.com | 100% | 3.2K | #7,045,168 | View details | |
| polydex.com | 100% | – | – | View details | |
aitanchem.com | aitanchem.com | 100% | – | – | – |
argosi.com.cn | argosi.com.cn | 100% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 19 similar websites and full traffic analytics for Neuland Labs
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 19 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Neuland Labs (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Neuland Labs
Complete news archive for Neuland Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neuland Labs
Neuland Labs was founded in 1984 and raised its 1st funding round 28 years after it was founded.
Neuland Labs is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Davuluri Sucheth Rao is the current CEO of Neuland Labs. They have also founded this company.
Neuland Labs has 1,790 employees.
The primary company behind Neuland Labs, Neuland Laboratories Ltd., reported revenue of ₹1,497 Cr for FY 2025, down 5% year on year.
Neuland Labs is involved in the development and manufacturing of active pharmaceutical ingredients (APIs) and offers contract development and manufacturing organization (CDMO) services. The company serves over 500 pharmaceutical and biotech organizations across 80 countries. Operations are focused on generic APIs, custom drug development, and peptide synthesis. Solutions are provided for early-stage drug development through commercial manufacturing, emphasizing quality, compliance, and innovation. Sectors served include healthcare and pharmaceuticals, with a commitment to sustainability and environmental responsibility integrated into processes.
Neuland Labs's top competitors include Laurus Labs, Symbiotec and Sterling Pharma Solutions.
Neuland Labs offers Generic APIs, CDMO Services, and Peptide Development.
Yes, Neuland Labs is publicly traded on NSE under the ticker symbol NEULANDLAB.
Neuland Labs has made 1 acquisition, including Arch Pharmalabs.
Neuland Labs has 1 investor. Key investors include Evolvence.
Neuland Labs operates through Neuland Laboratories Ltd..